Asian Institute of Nephrology and Urology 
Dealstreet

Khaitan advises Asian Institute of Nephrology and Urology on sale of majority stake to Asia Healthcare Holdings

The deal amount is valued at ₹600 crore.

Bar & Bench

The Asian Institute of Nephrology and Urology Private Limited ("AINU") has sold the majority stake by way of secondary sale and primary issuance of shares to Asia Healthcare Holdings Pte. Ltd. for an overall deal value of ₹600 crore.

Khaitan & Co advised AINU, the selling shareholders (including the promoters) and the exiting fund, HealthQuad Fund I in this transaction.

The core team consisted of Mayank Singh (Partner), Kevin Peter (Counsel), Kairavi Shah (Principal Associate), Esha Chauhan (Senior Associate), Hitakshi Mahendru (Senior Associate) with closing assistance from Mohnish Singh (Associate).

Mayank Singh

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Senior Advocate Satya Darshi Sanjay appointed Advocate General of Bihar

Shared auto not ‘workplace’ under POSH Act: Bombay HC grants relief to SBI employee accused of sexual harassment

Kerala High Court seeks response from Kerala Story 2's producer to plea for removal of film from Zee5

NLUO-CCJHR announces Double Credit Course on Cyber Crime and Cyber Forensics through the Lens of the Bharatiya Sakshya Adhiniyam

Judge should not sit like a sphinx, must engage with lawyers during hearings: Madras High Court

SCROLL FOR NEXT